Pathological examination of the biopsied specimens of the lesion demonstrated medium-differentiated adenocarcinoma, and immunohistochemistry of the tumor showed negative reactivity for human epidermal growth factor receptor 2 (HER2). The gene discussed is ERBB2; the disease is adenocarcinoma.